WY14643 Attenuates the Scopolamine-Induced Memory Impairments in Mice

详细信息    查看全文

• 作者：Hui Xu ; Zhengchen You ; Zhonghua Wu ; Liang Zhou ; Jianhong Shen…
• 关键词：Brain ; derived neurotrophic factor ; cAMP response element ; binding protein ; Memory ; Scopolamine ; WY14643
• 刊名：Neurochemical Research
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：41
• 期：11
• 页码：2868-2879
• 全文大小：1,952 KB
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Neurosciences
  Biochemistry
  Neurology
  
• 出版者：Springer Netherlands
• ISSN：1573-6903
• 卷排序：41

文摘

WY14643 is a selective agonist of peroxisome proliferator-activated receptor-α (PPAR-α) with neuroprotective and neurotrophic effects. The aim of this study was to evaluate the effects of WY14643 on cognitive impairments induced by scopolamine, a muscarinic acetylcholine receptor antagonist. We conducted different behavior tests including the Y-maze, Morris water maze, and passive avoidance test to measure the cognitive functions of C57BL/6J mice after scopolamine and WY14643 treatment. It was found that WY14643 injection significantly attenuated the scopolamine-induced cognitive impairments in these behavioral tests. Moreover, WY14643 treatment significantly enhanced the expression of brain-derived neurotrophic factor (BDNF) signaling cascade in the hippocampus. The usage of both PPAR-α inhibitor GW6471 and BDNF system inhibitor K252a fully prevented the memory-enhancing effects of WY14643. Therefore, these findings suggest that WY14643 could improve the scopolamine-induced memory impairments, and these effects are mediated by the activation of PPAR-α and BDNF system, thereby exhibiting a cognition-enhancing potential.